DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Esmirtazapine is an investigational drug.
There have been 9 clinical trials for Esmirtazapine. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2004.
The most common disease conditions in clinical trials are Sleep Initiation and Maintenance Disorders, Mental Disorders, and Dyssomnias. The leading clinical trial sponsors are Merck Sharp & Dohme Corp., Parexel, and [disabled in preview].
Recent Clinical Trials for Esmirtazapine
|Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007)||Merck Sharp & Dohme Corp.||Phase 3|
|A 6-Month Efficacy and Safety Study of Org 50081 in Adult Patients With Chronic Primary Insomnia (21106/P05701/MK-8265-002)||Merck Sharp & Dohme Corp.||Phase 3|
|A Long-Term Safety Study of Org 50081 (Esmirtazapine) in Elderly Outpatients With Chronic Primary Insomnia (176005/P05697/MK-8265-001)||Merck Sharp & Dohme Corp.||Phase 3|